Treatment Milestones in CML: Stay the Course or Change Therapy?
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Identify the response milestones associated with superior outcomes and summarize the treatment options outlined in the NCCN Guidelines based on response to TKI therapy
Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
- 0.75 Participation
- 0.86 Nurse
- 0.75 Pharmacist
- 0.75 Physician